Jonathan Parr, MD, Infectious Disease, Chapel Hill, NC, University of North Carolina Hospitals

JonathanParrMDMPH

Infectious Disease Chapel Hill, NC

HIV/AIDS Medicine, International Health, Travel & Tropical

Assistant Professor, Div of Infectious Diseases, University of North Carolina School of Medicine

Dr. Parr is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Parr's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalRESIDENCY
  • Harvard School of Public Health
    Harvard School of Public HealthOTHER_TRAINING
  • University of Virginia School of Medicine
    University of Virginia School of MedicineMEDICAL_SCHOOL
  • University of North Carolina School of Medicine
    University of North Carolina School of MedicineFELLOWSHIP

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2014 - 2020
  • MA State Medical License
    MA State Medical License 2010 - 2014
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • The Drug Tocilizumab for Rheumatoid Arthritis Is Insufficient in the Treatment of Covid-19 Patients in Hospital in Three Studies
    The Drug Tocilizumab for Rheumatoid Arthritis Is Insufficient in the Treatment of Covid-19 Patients in Hospital in Three Studies
  • Coronavirus Today – Oct. 21 – Paused in Phase 3; Counties Asked to Toughen COVID Restrictions; Promising Treatment Underperforms; Veterans’ Home Outbreaks
    Coronavirus Today – Oct. 21 – Paused in Phase 3; Counties Asked to Toughen COVID Restrictions; Promising Treatment Underperforms; Veterans’ Home Outbreaks
  • Rheumatoid Arthritis Drug Falls Short as Treatment for Hospitalized Covid-19 Patients in Three Studies
    Rheumatoid Arthritis Drug Falls Short as Treatment for Hospitalized Covid-19 Patients in Three Studies
  • Join now to see all

Hospital Affiliations